Search Results - Henk Codrington

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Is <sup>18</sup>F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer?

    Is <sup>18</sup>F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer? by Tjeerd S. Aukema, Ingrid Kappers, Renato A. Valdés Olmos, Henk Codrington, Harm van Tinteren, Renée van Pel, Houke M. Klomp

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer

    Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer by Eva E. Schaake, Ingrid Kappers, Henk Codrington, Renato A. Valdés Olmos, Hendrik J. Teertstra, Renée van Pel, Jacobus A. Burgers, Harm van Tinteren, Houke M. Klomp

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study

    A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study by Joachim G.J.V. Aerts, Henk Codrington, Nienke A. G. Lankheet, Sjaak A. Burgers, Bonne Biesma, Anne‐Marie C. Dingemans, Andrew Vincent, O. Dalesio, Harry J.M. Groen, Egbert F. Smit

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab

    Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab by Iris Walraven, Michel M. van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Joachim G.J.V. Aerts, Frederieke Koppe, Henk Codrington, Peter W.A. Kunst, Edith Dieleman, Paul van de Vaart, Marcel Verheij, J. Belderbos

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer

    The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer by Karlijn J.G. Schulkes, Esteban T.D. Souwer, Marije E. Hamaker, Henk Codrington, Simone van der Sar–van der Brugge, Jan‐Willem J. Lammers, Johanneke E.A. Portielje, Leontine J. R. van Elden, Frederiek van den Bos

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: